Characterization of an acute molecular marker of nongenotoxic rodent hepatocarcinogenesis by gene expression profiling in a long term clofibric acid study

Chemical Research in Toxicology

Volumn 18, Issue 4, 2005, Pages 611-618

  Michel, Cécile ^a,b   Roberts, Ruth A ^c   Desdouets, Chantal ^a   Isaacs, Kevin R ^d   Boitier, Eric ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SANOFI   (France)

^c ASTRAZENECA   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CLOFIBRIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER WEIGHT; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CLOFIBRIC ACID; GENE EXPRESSION PROFILING; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MULTIGENE FAMILY; NADPH-FERRIHEMOPROTEIN REDUCTASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 17644419635     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049705v     Document Type: Article

References (51)

1. Kramer, J. A., Curtiss, S. W., Kolaja, K. L., Alden, C. L., Blomme, E. A., Curtiss, W. C., Davila, J. C., Jackson, C. J., and Bunch, R. T. (2004) Acute molecular markers of rodent hepatic carcinogenesis identified by transcription profiling. Chem. Res. Toxicol. 17, 463-470.
2. Collins, F. S. (1997) Sequencing the human genome. Hosp. Pract. (Off. Ed.) 32, 35-39, 53.
3. Amundson, S. A., Bittner, M., Chen, Y., Trent, J., Meltzer, P., and Fornace, A. J., Jr. (1999) Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18, 3666-3672.
4. Waring, J. F., Jolly, R. A., Ciurlionis, R., Lum, P. Y., Praestgaard, J. T., Morfitt, D. C., Buratto, B., Roberts, C., Schadt, E., and Ulrich, R. G. (2001) Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175, 28-42.
5. Council Directive of November 24 on the approximation of laws, r. a. a. p. o. t. M. S. r. t. p. o. a. u. f. e. a. o. s. p. (1986) EEC Directive. Off. J. Eur. Commun. L358.
6. Scherer, E., and Emmelot, P. (1975) Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat. Eur. J. Cancer 11, 689-696.
7. Squire, R. A., and Levitt, M. H. (1975) Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 35, 3214-3223.
8. Vesselinovitch, S. D., Hacker, H. J., and Bannasch, P. (1985) Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice. Cancer Res. 45, 2774-2780.
9. Theilhaber, J., Malanthara, A., Ulyanov, A., Cole, J., Xu, D., Nahf, R., Heuer, M., Brockel, C., and Bushnell, S. (2004) Gecko: A complete large-scale gene expression analysis platform. BMC Bioinformatics.
10. Theilhaber, J., Bushnell, S., Jackson, A., and Fuchs, R. (2001) Bayesian estimation of fold-changes in the analysis of gene expression: The PFOLD algorithm. J. Comput. Biol. 8, 585-614.
11. Toronen, P., Kolehmainen, M., Wong, G., and Castren, E. (1999) Analysis of gene expression data using self-organizing maps. FEBS Lett. 451, 142-146.
12. Fukuwatari, T., Suzuki, Y., Sugimoto, E., and Shibata, K. (2002) Elucidation of the toxic mechanism of the plasticizers, phthalic acid esters, putative endocrine disrupters: effects of dietary di-(2-ethylhexyl)phthalate on the metabolism of tryptophan to niacin in rats. Biosci., Biotechnol., Biochem. 66, 705-710.
13. Morton, N. M., Holmes, M. C., Fievet, C., Staels, B., Tailleux, A., Mullins, J. J., and Seckl, J. R. (2001) Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 276, 41293-41300.
14. Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M., Deng, C. X., and McKeehan, W. L. (2000) Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275, 15482-15489.
15. Brem, A. S., Bina, R. B., Mehta, S., and Marshall, J. (1999) Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol. Genet. Metab. 67, 53-57.
16. Keyse, S. M., and Emslie, E. A. (1992) Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359, 644-647.
17. Cherkaoui-Malki, M., Meyer, K., Cao, W. Q., Latruffe, N., Yeldandi, A. V., Rao, M. S., Bradfield, C. A., and Reddy, J. K. (2001) Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expression 9, 291-304.
18. Yamasaki, H., Ashby, J., Bignami, M., Jongen, W., Linnainmaa, K., Newbold, R. F., Nguyen-Ba, G., Parodi, S., Rivedal, E., Schiffmann, D., Simons, J. W., and Vasseur, P. (1996) Nongenotoxic carcinogens: Development of detection methods based on mechanisms: a European project. Mutat. Res. 353, 47-63.
19. Marsman, D. S., and Popp, J. A. (1994) Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis 15, 111-117.
20. Cattley, R. C., and Popp, J. A. (1989) Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res. 49, 3246-3251.
21. Oesterle, D., and Deml, E. (1983) Promoting effect of polychlorinated biphenyls on development of enzyme-altered islands in livers of weanling and adult rats. J. Cancer Res. Clin. Oncol. 105, 141-147.
22. Solt, D., and Farber, E. (1976) New principle for the analysis of chemical carcinogenesis. Nature 236, 702-703.
23. Schulte-Hermann, R. (1985) Tumor promotion in the liver. Arch. Toxicol. 57, 147-158.
24. Savonet, V., Maenhaut, C., Miot, F., and Pirson, I. (1997) Pitfalls in the use of several "housekeeping" genes as standards for quantitation of mRNA: The example of thyroid cells. Anal. Biochem. 247, 165-167.
25. Hamadeh, H. K., Bushel, P. R., Jayadev, S., Martin, K., DiSorbo, O., Sieber, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J. C., Blanchard, K., Paules, R. S., and Afshari, C. A. (2002) Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67, 219-231.
26. Nakashiro, K., Kawamata, H., Hino, S., Uchida, D., Miwa, Y., Hamano, H., Omotehara, F., Yoshida, H., and Sato, M. (1998) Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res. 58, 549-555.
27. Rester, H. A., Blanchetot, C., den Hertog, J., van der Saag, P. T., and van der, B. B. (1999) Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J. Biol. Chem. 274, 27439-27447.
28. Rester, H. A., Ward-van Oostwaard, T. M., Goumans, M. J., van Rooijen, M. A., Der Saag, P. T., van der, B. B., and Mummery, C. L. (2000) Expression of TGF-beta stimulated clone-22 (TSC-22) in mouse development and TGF-beta signaling. Dev. Dyn. 218, 563-572.
29. Higashi, K., Hiai, H., Higashi, T., and Muramatsu, M. (2004) Regulatory mechanism of glutathione S-transferase P-form during chemical hepatocarcinogenesis: Old wine in a new bottle. Cancer Lett. 209, 155-163.
30. Jalanko, H., and Ruoslahti, E. (1979) Differential expression of alpha-fetoprotein and gamma-glutamyltranspeptidase in chemical and spontaneous hepatocarcinogenesis. Cancer Res. 39, 3495-3501.
31. Rao, M. S., Nemali, M. R., Usuda, N., Scarpelli, D. G., Makino, T., Pitot, H. C., and Reddy, J. R. (1988) Lack of expression of glutathione-S- transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res. 48, 4919-4925.
32. Bayly, A. C., Roberts, R. A., and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol. 125, 197-203.
33. Roberts, R. A., Soames, A. R., Gill, J. H., James, N. H., and Wheeldon, E. B. (1995) Nongenotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 16, 1693-1698.
34. Ohta, S., Yanagihara, R., and Nagata, R. (1997) Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem. J. 324 (Part 3), 777-782.
35. Hino, S., Kawamata, H., Omotehara, F., Uchida, D., Miwa, Y., Begum, N. M., Yoshida, H., Sato, M., and Fujimori, T. (2002) Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells. Biochem. Biophys. Res. Commun. 292, 957-963.
36. Bursch, W., Oberhammer, F., Jirtle, R. L., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A. F., and Schulte-Hermann, R. (1993) Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br. J. Cancer 67, 531-536.
37. Rawamata, H., Nakashiro, R., Uchida, D., Hino, S., Omotehara, F., Yoshida, H., and Sato, M. (1998) Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br. J. Cancer 77, 71-78.
38. Yu, C., Wang, F., Jin, C., Wu, X., Chan, W. R., and McKeehan, W. L. (2002) Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am. J. Pathol. 161, 2003-2010.
39. Unoki, M., and Nakamura, Y. (2001) Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20, 4457-4465.
40. Saito, R., Markey, S. P., and Heyes, M. P. (1994) 6-Chloro-D,L- tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci. Lett. 178, 211-215.
41. Kotev-Emeth, S., Pitaru, S., Pri-Chen, S., and Savion, N. (2002) Establishment of a rat long-term culture expressing the osteogenic phenotype: Dependence on dexamethasone and FGF-2. Connect. Tissue Res. 43, 606-612.
42. Mizuno, H., and Nishida, E. (2001) The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes Cells 6, 261-268.
43. Riva, M. A., Molteni, R., and Racagni, G. (1998) Differential regulation of FGF-2 and FGFR-1 in rat cortical astrocytes by dexamethasone and isoproterenol. Brain Res. Mol. Brain Res. 57, 38-45.
44. Clark, A. R. (2003) MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids? J. Endocrinol. 178, 5-12.
45. Engelbrecht, Y., de Wet, H., Horsch, K., Langeveldt, C. R., Hough, F. S., and Hulley, P. A. (2003) Glucocorticoids induce rapid upregulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144, 412-422.
46. Wu, W., Chaudhuri, S., Brickley, D. R., Pang, D., Karrison, T., and Conzen, S. D. (2004) Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res. 64, 1757-1764.
47. Leung, Y. F., Tam, P. O., Lee, W. S., Lam, D. S., Yam, H. F., Fan, B. J., Tham, C. C., Chua, J. K., and Pang, C. P. (2003) The dual role of dexamethasone on antiinflammation and outflow resistance demonstrated in cultured human trabecular meshwork cells. Mol. Vision 9, 425-439.
48. Shibanuma, M., Kuroki, T., and Nose, K. (1992) Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J. Biol. Chem. 267, 10219-10224.
49. Miyata, K. S., McCaw, S. E., Meertens, L. M., Patel, H. V., Rachubinski, R. A., and Capone, J. P. (1998) Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor alpha. Mol. Cell. Endocrinol. 146, 69-76.
50. Subramaniam, N., Treuter, E., and Okret, S. (1999) Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. J. Biol. Chem. 274, 18121-18127.
51. Chiang, D. Y., Brown, P. O., and Eisen, M. B. (2001) Visualizing association between genome sequences and gene expression data using genome-mean expression profiles. Bioinformatics 17, 49S-55S.